Curie Therapeutics Expands Radiopharmaceutical Expertise with Appointment of Bernard Lambert, Ph.D. Source:   Business Wire   02-13-2022 06:00:45
Curie Therapeutics Inc. ("Curie"), a biotechnology company focused on developing innovative radiopharmaceutical therapies for oncological diseases, today announced the appointment of Bernard Lambert, Ph.D., as Chief Technology Officer. Dr. Lambert joins Curie Therapeutics to lead the Company’s process development, manufacturing, and technical operations.

Read All



    About Privacy Contact Us © 2016